Novel vaccines and treatments are increasingly required to deal with an expanding range of global healthcare challenges. The current worldwide outbreak of Covid-19 has clearly demonstrated the urgent need for the rapid development of therapies, accelerated drug production, and novel vaccine development. AI is a useful tool for the optimization of vaccine production as well as for understanding logistical issues during pandemics. Advanced Machine Learning can significantly enhance the efficiency and effectiveness of randomized control trials, which are a crucial rapid and reliable testing phase of drugs. In addition, ML algorithms can eliminate the impact of human error and bias in data collection and processing.